ASX Small Cap News 31 January 2025
31st of January brings us to the end of the Appendix 4C season for those companies required to do so. It also opens the door to reporting season, which will begin on Monday and will see most of the ASX-listed companies release their half-yearly or annual report. Here's what was interesting in ASX small caps. Medical Developments (MVP) Market Cap: $74.9m Share price movement: 51.1% Medical Developments International Limited has released its quarterly cash flow report for the period ending December 31, 2024, showing significant improvements in operating cash flow and revenue. The company reported $10.9 million in revenue for Q2 FY25, an increase of $1.8 million from the previous quarter, driven by higher demand for its pain management product, Penthrox. The cash flow from operating activities was $1.9 million, indicating a strong recovery compared to previous periods. The company […]
